Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (161-170 of 481) with videos related to

Pageof 49
Sort By:
Blood|May 5, 2012
Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancerXin Yao, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
The New England Journal of Medicine|November 15, 2013
Low-intensity therapy in adults with Burkitt's lymphomaKieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.
American Journal of Hematology|January 15, 2025
Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion LymphomaKathryn Lurain, Ramya Ramaswami, Eric Oksenhendler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantationNirali N Shah, Michael J Borowitz, Seth M Steinberg, et al.
Cancer|June 15, 2007
A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profilingEdwin M Posadas, Virginia Kwitkowski, Herbert L Kotz, et al.
Cancers|February 24, 2024
Pulmonary Metastasectomy for Adrenocortical Carcinoma-Not If, but WhenShamus R Carr, Frank Villa Hernandez, Diana Grace Varghese, et al.
The Journal of Urology|April 12, 2005
A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapyJames L Gulley, William D Figg, Seth M Steinberg, et al.
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2Christina M Annunziata, Amanda J Walker, Lori Minasian, et al.
Annals of Surgical Oncology|July 29, 2018
An Examination of Applicants and Factors Associated with Matriculation to Complex General Surgical Oncology Fellowship Training ProgramsMichael M Wach, Samantha M Ruff, Reed I Ayabe, et al.
Pageof 49

Showing results (161-170 of 481) with videos related to

Sort By:
Pageof 49
Blood|May 5, 2012
Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancerXin Yao, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
The New England Journal of Medicine|November 15, 2013
Low-intensity therapy in adults with Burkitt's lymphomaKieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.
American Journal of Hematology|January 15, 2025
Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion LymphomaKathryn Lurain, Ramya Ramaswami, Eric Oksenhendler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2014
Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantationNirali N Shah, Michael J Borowitz, Seth M Steinberg, et al.
Cancer|June 15, 2007
A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profilingEdwin M Posadas, Virginia Kwitkowski, Herbert L Kotz, et al.
Cancers|February 24, 2024
Pulmonary Metastasectomy for Adrenocortical Carcinoma-Not If, but WhenShamus R Carr, Frank Villa Hernandez, Diana Grace Varghese, et al.
The Journal of Urology|April 12, 2005
A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapyJames L Gulley, William D Figg, Seth M Steinberg, et al.
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2Christina M Annunziata, Amanda J Walker, Lori Minasian, et al.
Annals of Surgical Oncology|July 29, 2018
An Examination of Applicants and Factors Associated with Matriculation to Complex General Surgical Oncology Fellowship Training ProgramsMichael M Wach, Samantha M Ruff, Reed I Ayabe, et al.
Pageof 49